GLP-1 Medication
— Oral Semaglutide (Rybelsus)
As GLP-1 receptor agonists gain traction in weight-management and metabolic care, oral semaglutide — marketed as Rybelsus® — offers a unique non-injectable option driven by the same hormone-modulating science found in injectable GLP-1 drugs like Ozempic and Wegovy.
What Is Oral Semaglutide (Rybelsus)?
- Increase insulin secretion in response to meals
- Slow gastric emptying
- Suppress appetite and reduce cravings
These mechanisms support a caloric deficit and help many patients lose weight when combined with lifestyle changes.
How Oral Semaglutide Works
Oral semaglutide activates the GLP-1 pathway in the gut and brain to regulate hunger, enhance fullness, and improve glucose metabolism. Because it’s taken as a daily tablet, its absorption depends on how and when it’s taken relative to food and liquids (proper administration maximises its effectiveness).
Dosage & Administration
Rybelsus tablets are available in several strengths — typically 3 mg, 7 mg, and 14 mg — and are generally stepped up gradually to improve tolerability.
How to take Rybelsus:
- Take once daily in the morning on an empty stomach
- Use no more than a small sip of water (≈120 mL)
- Wait at least 30 minutes before eating, drinking, or taking other medicines
These steps help maximise absorption in the stomach.
If a dose is missed, skip it and resume the next day — do not double up.
Effectiveness for Weight Management
Clinical evidence shows that oral semaglutide can support meaningful weight reduction when paired with a balanced diet and physical activity. In trial data, patients taking higher doses have shown noticeable weight loss compared to placebo, although results tend to be more modest than weekly injectable GLP-1 options like Wegovy or Mounjaro.
Typical outcomes reported in Singapore practice indicate several-percent reductions in body weight over months of daily use, with individual results varying.
Safety & Side Effects
Oral semaglutide shares a similar side-effect profile with other GLP-1 medications. Common, generally mild effects include:
- Nausea and vomiting
- Bloating or abdominal discomfort
- Diarrhoea or constipation
These symptoms often improve after the first few weeks as your body adjusts.
More serious but less common risks include pancreatitis or gallbladder issues — particularly in individuals with relevant histories — so clinical oversight is important.
Who Might Be a Good Candidate
Daily oral semaglutide can be a suitable choice for people who:
- Prefer a tablet over injections
- Are managing type 2 diabetes and weight concurrently
- Want a medically supported GLP-1 strategy under doctor's supervision.
In Singapore, a clinician will assess your health profile and goals before prescribing Rybelsus.
Rybelsus may not be suitable for people who are pregnant or breastfeeding, those with a history of certain thyroid cancers, or individuals with specific gastrointestinal conditions — consult your doctor for personalised advice.
How Rybelsus Fits Within the GLP-1 Landscape
GLP-1 receptor agonists now come in several forms:
- Injectable weekly options (e.g., Ozempic, Wegovy)
- Daily oral tablets (Rybelsus)
Each has pros and cons, and your doctor can help decide which matches your lifestyle and treatment goals best.
Summary — Key Points on Oral Semaglutide
| Aspect | Rybelsus (Oral Semaglutide) |
|---|---|
|
Medication Type |
GLP-1 receptor agonist tablet |
|
Administration |
Once daily on an empty stomach |
|
Main Uses |
Type 2 diabetes; weight management under supervision |
|
Appetite Effects |
Reduces hunger, slows stomach emptying |
|
Weight Loss |
Effective, generally modest vs injectables |
|
Side Effects |
GI-related, usually transient |
|
Suitability |
Adults with guidance from a clinician |
Contact Us
Book An Appointment Now
Take the first step toward a healthier, more confident you. Our medical team is ready to answer your questions and guide you through safe, personalised weight-loss options. Reach out today to schedule a consultation or speak with our care specialists.